These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 4391090)

  • 1. The negative inotropic effect of adrenergic betareceptor blocking drugs on human heart muscle.
    Nayler WG; Chipperfield D; Lowe TE
    Cardiovasc Res; 1969 Jan; 3(1):30-6. PubMed ID: 4391090
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative effects of sotalol and propranolol on contractility of papillary muscles and adenyl cyclase activity of myocardial extracts of cat.
    Parmley WW; Rabinowitz B; Chuck L; Bonorris G; Katz JP
    J Clin Pharmacol New Drugs; 1972 Apr; 12(4):127-35. PubMed ID: 4401703
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of the cardiac effects of several beta adrenergic blocking agents.
    Blinks JR
    Ann N Y Acad Sci; 1967 Feb; 139(3):673-85. PubMed ID: 4382727
    [No Abstract]   [Full Text] [Related]  

  • 4. Catecholamine stores and the negative inotropic effect of beta-adrenergic blocking drugs on the isolated rabbit heart.
    Levy JV
    Arch Int Physiol Biochim; 1967 Jun; 75(3):381-404. PubMed ID: 4167703
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological properties of H 56-28--a beta-adrenergic receptor antagonist.
    Ablad B; Brogård M; Ek L
    Acta Pharmacol Toxicol (Copenh); 1967; 25():9-40. PubMed ID: 6072577
    [No Abstract]   [Full Text] [Related]  

  • 6. Trasicor: review of the pharmacology and clinical results.
    Fuccella LM
    S Afr Med J; 1969 Dec; ():Suppl:7-14. PubMed ID: 4190429
    [No Abstract]   [Full Text] [Related]  

  • 7. The action of practolol and propranolol on the rabbit isolated atrium.
    Wale J
    Eur J Pharmacol; 1970 Mar; 9(3):387-90. PubMed ID: 4392487
    [No Abstract]   [Full Text] [Related]  

  • 8. Beta adrenergic blocking and cardiovascular properties of two new substances, Kö 1313 and Kö 1366.
    Baum T; Rowles G; Shropshire AT; Gluckman MI
    J Pharmacol Exp Ther; 1971 Feb; 176(2):339-49. PubMed ID: 4398186
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of beta-adrenergic blocking activity of DCI, H56-28, ICI50172, LB46, methoxamine, MJ1999 and propranolol in the blood perfused canine papillary muscle preparation.
    Hashimoto K; Endoh M; Tamura K; Taira N
    Experientia; 1970; 26(7):757-9. PubMed ID: 4393455
    [No Abstract]   [Full Text] [Related]  

  • 10. Glucagon. Its enhancement of cardiac performance in the cat and dog and persistence of its inotropic action despite beta-receptor blockade with propranolol.
    Glick G; Parmley WW; Wechsler AS; Sonnenblick EH
    Circ Res; 1968 Jun; 22(6):789-99. PubMed ID: 5659816
    [No Abstract]   [Full Text] [Related]  

  • 11. The cardiovascular pharmacology of bunolol, a new beta adrenergic blocking agent.
    Robson RD; Kaplan HR
    J Pharmacol Exp Ther; 1970 Oct; 175(1):157-67. PubMed ID: 4394301
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative actions of beta-adrenergic receptor blocking drugs on the contractile and electrical properties of isolated human atrial muscle.
    Levy JV
    Cardiologia (Basel); 1968; 53(5):293-305. PubMed ID: 4391736
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiovascular effects of prinodolol (LB-46), a potent beta-adrenergic receptor antagonist.
    Levy JV
    J Clin Pharmacol New Drugs; 1971; 11(4):249-60. PubMed ID: 4397374
    [No Abstract]   [Full Text] [Related]  

  • 14. Beta-adrenergic receptor blocking properties of three allyl-substituted phenoxypropanolamines.
    Ablad B; Brogård M; Carlsson E; Ek L
    Eur J Pharmacol; 1970; 13(1):59-64. PubMed ID: 4395676
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of -adrenoreceptor blocking drugs on isolated skeletal and cardiac muscle.
    Harry JD; Linden RJ; Snow HM
    Br J Pharmacol; 1971 Oct; 43(2):453P-454P. PubMed ID: 4400575
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of caffeine and other methylxanthines on mechanical properties of isolated mammalian heart muscle. Evidence for a dual mechanism of action.
    Blinks JR; Olson CB; Jewell BR; Bravený P
    Circ Res; 1972 Apr; 30(4):367-92. PubMed ID: 4401230
    [No Abstract]   [Full Text] [Related]  

  • 17. -Adrenergic blocking agents of the chromone and xanthone groups. II. Propranolol type derivatives.
    Da Re P; Primofiore GP; Bertelli A
    J Med Chem; 1972 Aug; 15(8):868-9. PubMed ID: 4402954
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative partial agonist activity of -adrenoceptor antagonists.
    Nayler WG
    Br J Pharmacol; 1972 Jun; 45(2):382-4. PubMed ID: 4403104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of beta-adrenoceptor blocking drugs on the chronotropic and inotropic actions of isoprenaline on the acutely denervated dog heart.
    Harry JD; Kappagoda CT; Linden RJ; Snow HM
    Br J Pharmacol; 1971 Feb; 41(2):387P-389P. PubMed ID: 4396704
    [No Abstract]   [Full Text] [Related]  

  • 20. Inotropic and chronotropic effects of a series of beta-adrenergic blocking drugs: some structure-activity relationships.
    Levy JV; Richards V
    Proc Soc Exp Biol Med; 1966 Jun; 122(2):373-9. PubMed ID: 4382783
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.